A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature


Submitted: July 9, 2014
Accepted: July 9, 2014
Published: June 30, 2014
Abstract Views: 2810
PDF: 1256
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Orcun Celik Tepecik Educational and Research Hospital Urology Department, 35140, Izmir, Turkey.
  • Salih Budak Tepecik Educational and Research Hospital Urology Department, 35140, Izmir, Turkey.
  • Gokhan Ekin Tepecik Educational and Research Hospital Urology Department, 35140, Izmir, Turkey.
  • Ilker Akarken Tepecik Educational and Research Hospital Urology Department, 35140, Izmir, Turkey.
  • Yusuf Ozlem Ilbey Tepecik Educational and Research Hospital Urology Department, 35140, Izmir, Turkey.
Primary signet cell carcinoma of the prostate is a rare histological variant of prostate malignancies. It is commonly originated from the stomach, colon, pancreas, and less commonly in the bladder. Prognosis of the classical type is worse than the adenocarcinoma of the prostate. Primary signet cell adenocarcinoma is diagnosed by eliminating the adenocarcinomas of other organs such as gastrointestinal tract organs. In this case report, we present a case with primary signet cell adenocarcinoma of the prostate who received docetaxel chemotherapy because of short prostate specific antigen doubling time.

Celik, O., Budak, S., Ekin, G., Akarken, I., & Ilbey, Y. O. (2014). A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature. Archivio Italiano Di Urologia E Andrologia, 86(2), 148–149. https://doi.org/10.4081/aiua.2014.2.148

Downloads

Download data is not yet available.

Citations